Literature DB >> 33658003

How do you manage ANTICOagulant therapy in neurosurgery? The ANTICO survey of the Italian Society of Neurosurgery (SINCH).

Alessandro Prior1, Pietro Fiaschi2,3, Corrado Iaccarino4, Roberto Stefini5, Denise Battaglini6,7, Alberto Balestrino1, Pasquale Anania1, Enrico Prior8, Gianluigi Zona1,9.   

Abstract

BACKGROUND: Anticoagulant assumption is a concern in neurosurgical patient that implies a delicate balance between the risk of thromboembolism versus the risk of peri- and postoperative hemorrhage.
METHODS: We performed a survey among 129 different neurosurgical departments in Italy to evaluate practice patterns regarding the management of neurosurgical patients taking anticoagulant drugs. Furthermore, we reviewed the available literature, with the aim of providing a comprehensive but practical summary of current recommendations.
RESULTS: Our survey revealed that there is a lack of knowledge, mostly regarding the indication and the strategies of anticoagulant reversal in neurosurgical clinical practice. This may be due a lack of national and international guidelines for the care of anticoagulated neurosurgical patients, along with the fact that coagulation and hemostasis are not simple topics for a neurosurgeon.
CONCLUSIONS: To overcome this issue, establishment of hospital-wide policy concerning management of anticoagulated patients and developed in an interdisciplinary manner are strongly recommended.

Entities:  

Keywords:  Anticoagulant; Neurosurgery; Reversal therapy; Spontaneous intracerebral hemorrhage; Traumatic brain injury

Mesh:

Substances:

Year:  2021        PMID: 33658003      PMCID: PMC7927258          DOI: 10.1186/s12883-021-02126-7

Source DB:  PubMed          Journal:  BMC Neurol        ISSN: 1471-2377            Impact factor:   2.474


  107 in total

1.  Efficacy and safety of a prothrombin complex concentrate (Octaplex) for rapid reversal of oral anticoagulation.

Authors:  Aaron Lubetsky; Ron Hoffman; Reuven Zimlichman; Amiram Eldor; Joseph Zvi; Viktor Kostenko; Benjamin Brenner
Journal:  Thromb Res       Date:  2004       Impact factor: 3.944

2.  [Summary of the article: Patel MR, Mahaffey KW, Garg J et al. Rivaroxaban versus warfarin in nonvalvular atrial fibrillation. N Engl J Med, 2011; 365: 1557-1559].

Authors:  Ewa Szczerba
Journal:  Kardiol Pol       Date:  2012       Impact factor: 3.108

3.  Acute subdural hematoma in patients on oral anticoagulant therapy: management and outcome.

Authors:  Sae-Yeon Won; Daniel Dubinski; Markus Bruder; Adriano Cattani; Volker Seifert; Juergen Konczalla
Journal:  Neurosurg Focus       Date:  2017-11       Impact factor: 4.047

4.  Antithrombotic Therapy for Atrial Fibrillation: CHEST Guideline and Expert Panel Report.

Authors:  Gregory Y H Lip; Amitava Banerjee; Giuseppe Boriani; Chern En Chiang; Ramiz Fargo; Ben Freedman; Deirdre A Lane; Christian T Ruff; Mintu Turakhia; David Werring; Sheena Patel; Lisa Moores
Journal:  Chest       Date:  2018-08-22       Impact factor: 9.410

5.  Efficacy and safety of a 4-factor prothrombin complex concentrate in patients on vitamin K antagonists presenting with major bleeding: a randomized, plasma-controlled, phase IIIb study.

Authors:  Ravi Sarode; Truman J Milling; Majed A Refaai; Antoinette Mangione; Astrid Schneider; Billie L Durn; Joshua N Goldstein
Journal:  Circulation       Date:  2013-08-09       Impact factor: 29.690

6.  Early Clinical and Radiological Course, Management, and Outcome of Intracerebral Hemorrhage Related to New Oral Anticoagulants.

Authors:  Jan C Purrucker; Kirsten Haas; Timolaos Rizos; Shujah Khan; Marcel Wolf; Michael G Hennerici; Sven Poli; Christoph Kleinschnitz; Thorsten Steiner; Peter U Heuschmann; Roland Veltkamp
Journal:  JAMA Neurol       Date:  2016-02       Impact factor: 18.302

Review 7.  Clinical diagnosis of cerebral amyloid angiopathy: validation of the Boston criteria.

Authors:  Eric E Smith; Steven M Greenberg
Journal:  Curr Atheroscler Rep       Date:  2003-07       Impact factor: 5.113

Review 8.  What Surgeons Should Know About Non-Vitamin K Oral Anticoagulants: A Review.

Authors:  Atul Verma; Andrew C T Ha; James T Rutka; Subodh Verma
Journal:  JAMA Surg       Date:  2018-06-01       Impact factor: 14.766

9.  Association of Antithrombotic Drug Use With Subdural Hematoma Risk.

Authors:  David Gaist; Luis Alberto García Rodríguez; Maja Hellfritzsch; Frantz Rom Poulsen; Bo Halle; Jesper Hallas; Anton Pottegård
Journal:  JAMA       Date:  2017-02-28       Impact factor: 56.272

10.  Comparing intracerebral hemorrhages associated with direct oral anticoagulants or warfarin.

Authors:  Ryota Kurogi; Kunihiro Nishimura; Michikazu Nakai; Akiko Kada; Satoru Kamitani; Jyoji Nakagawara; Kazunori Toyoda; Kuniaki Ogasawara; Junichi Ono; Yoshiaki Shiokawa; Toru Aruga; Shigeru Miyachi; Izumi Nagata; Shinya Matsuda; Shinichi Yoshimura; Kazuo Okuchi; Akifumi Suzuki; Fumiaki Nakamura; Daisuke Onozuka; Keisuke Ido; Ai Kurogi; Nobutaka Mukae; Ataru Nishimura; Koichi Arimura; Takanari Kitazono; Akihito Hagihara; Koji Iihara
Journal:  Neurology       Date:  2018-02-28       Impact factor: 9.910

View more
  1 in total

1.  The effect of antithrombotic therapy on the recurrence and outcome of chronic subdural hematoma after burr-hole craniostomy in a population-based cohort.

Authors:  Olli-Pekka Kämäräinen; Nils Danner; Santtu Kerttula; Jukka Huttunen; Ville Leinonen
Journal:  Acta Neurochir (Wien)       Date:  2022-08-16       Impact factor: 2.816

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.